Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial

Autor:	Vatche Tchekmedyian, Lara Dunn, Eric Sherman, Shrujal S. Baxi, Ravinder K. Grewal, Steven M. Larson, Keith S. Pentlow, Sofia Haque, R. Michael Tuttle, Mona M. Sabra, Stephanie Fish, Laura Boucai, Jamie Walters, Ronald A. Ghossein, Venkatraman E. Seshan, Jeffrey A. Knauf, David G. Pfister, James A. Fagin, Alan L. Ho
Rok vydání:	2022
Předmět:	Endocrinology Endocrinology Diabetes and Metabolism
Zdroj:	Thyroid. 32:273-282
ISSN:	1557-9077 1050-7256
DOI:	10.1089/thy.2021.0565
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::dad176b1cb35f557bbbd911ed137bcf1 https://doi.org/10.1089/thy.2021.0565 Zobrazit plný text záznamu